To date, there is a lack of characterization of metabolic markers in migraine studies. Though numerous studies implicate cerebral dysfunction, robust biomarkers are yet to be identified in the migraine brain. It thus follows that identification of specific metabolic changes, potentially influenced by excitatory and inhibitory neurotransmitters, may improve understanding of migraine onset and propagation while opening new avenues for therapy development.
With the goal of evaluating metabolic processes, diffusion-weighed spectroscopy is used to identify longitudinal changes in the in vivo thalamus of an acute rodent of migraine model.
Acute and sustained biochemical changes, prominently with lactate, taurine and total creatine, have been identified previously in a 1H-MRS neocortical study [1], indicative of increased neural activity/glycolysis and supported by dynamically altered sodium homeostasis [2]. These metabolites demonstrated dynamic and longitudinal changes in concentration following intraperitoneal (IP) injection of nitroglycerin (NTG). However, other potential metabolites of interest, namely those attributed to excitability (e.g., NAA and glutamate signals in neurons, myoinositol, choline and glutamine signals in astrocytes [4,5]), did not display significant concentration changes with NTG. However, diffusion-weighted (DW-MRS) [6-8,10] may prove more sensitive for detecting cell specific alterations in endogenous metabolites with migraine onset.
In
this study, DW-MRS was employed to measure diffusion properties and
compartmental changes in an NTG rat model. Compartmentalization and shuttling
of metabolites between cells is believed, during the ictal state, to be an
important factor in migraine [10] that impacts
metabolism and function. Due to its central role in migraine, the thalamus is
the target of these in vivo
investigations, for which the high sensitivity of 21.1-T MRS will be leveraged
to monitor concentration and diffusional alteration metabolites during the progression
of migraine.
Animal Model: Under sedation in the magnet, ten Sprague-Dawley male rats were administered in situ with an IP injection of either 10 mg/kg of NTG to provide conditions of a migraine analogue (n=6) or saline (n=4) to serve as controls.
MR Acquisitions: All scans were performed using the 21.1-T ultra-wide bore magnet at the US National High Magnetic Field Laboratory and a linear 1H/23Na birdcage coil. DW-MRS was acquired using a relaxation enhanced MRS (RE-MRS) sequence to target upfield metabolites from a 3x4x3-mm voxel localized in the thalamus and without water suppression. Selective bandwidth excitation was accomplished with a 5-ms sinc-10 pulse, with a 5-ms 180° SLR refocusing pulse, exciting a band between 0-4 ppm. Localization was achieved using six 5-ms adiabatic pulses by adiabatic selective refocusing (3D LASER). Due to fiber orientation in the thalamus, three diffusion weightings were applied in equally weighted directions using an optimized diffusion time of 15 ms to achieve b values of 0, 1640 and 3857 s/mm2. With TE/TR=64/2500 ms and NA=120, the total acquisition time of 15 min. A total of two pre-injection scans (for baseline data) and five post-injection scans were acquired (~2.5-h post injection).
Data Analysis: Data was acquired as a partial echo, and magnitude spectra were generated after apodization (10-Hz exponential line broadening) and Fourier transform. No other deconvolution of spectral components was performed. The apparent diffusion coefficient (ADC) values were calculated for each metabolite using a mono-exponential fit. Unweighted (b=0 s/mm2) spectra also were used to track signal intensity changes, with the intensity time course normalized to the average of the baseline (pre-injection) signal for each peak. A mixed model ANOVA with repeated measures was used to establish within and between group significances.
[1] Abad N, Rosenberg JT, Roussel T, Grice DC, Harrington MG, Grant SC. Metabolic Assessment of a Migraine Model Using Relaxation-Enhanced 1H Spectroscopy at Ultrahigh Field. Magnetic Resonance in Medicine 2017;79:1266-1275.
[2] Abad N, Rosenberg JT, Hike DC, Harrington MG, Grant SC. Dynamic sodium imaging at ultra-high field reveals progression in a preclinical migraine model. Pain 2018;159:2058-2065.
[3] Arngrim N, Schytz HW, Britze J, Amin FM, Vestergaard MB, Hougaard A, Wolfram F, de Koning PJH, Olsen KS, Secher NH, Larsson HBW, Olesen J, Ashina M. Migraine induced by hypoxia: an MRI spectroscopy and angiography study. Brain 2016;139:723-737.
[4] Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65:1-105.
[5] EreciĆska M SI. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35:245.
[6] Ligneul C, Valette J. Probing metabolite diffusion at ultra-short time scales in the mouse brain using optimized oscillating gradients and "short"-echo-time diffusion-weighted MRS. NMR Biomed 2017;30:10.1002/nbm.3671. Epub 2016 Nov 28.
[7] Ronen I, Ercan E, Webb A. Axonal and glial microstructural information obtained with diffusion-weighted magnetic resonance spectroscopy at 7T. Front Integr Neurosci 2013;7:13.
[8] Valette J, Guillermier M, Besret L, Boumezbeur F, Hantraye P, Lebon V. Optimized diffusion-weighted spectroscopy for measuring brain glutamate apparent diffusion coefficient on a whole-body MR system. NMR Biomed 2005;18:527-533.
[9] Zielman R, Teeuwisse WM, Bakels F, Van der Grond J, Webb A, van Buchem MA, Ferrari MD, Kruit MC, Terwindt GM. Biochemical changes in the brain of hemiplegic migraine patients measured with 7 tesla H-1-MRS. Cephalalgia 2014;34:959-967.
[10] Zielman R, Wijnen JP, Webb A, Onderwater GLJ, Ronen I, Ferrari MD, Kan HE, Terwindt GM, Kruit MC. Cortical glutamate in migraine. Brain 2017;140:1859-1871.
[11] Papp EA, Leergaard TB, Calabrese E, Johnson GA, Bjaalie JG. Waxholm Space atlas of the Sprague Dawley rat brain. Neuroimage 2014;97:374-386.
Figure 1. Representative in vivo rat brain thalamus spectra acquired at 21.1 T displaying metabolite peak assignment. Insert demonstrates the 3x4x3-mm voxel placement in the coronal anatomical direction, overlaid with a FA map [11] (three primary colors, red, green and blue were assigned to DWI(x), DWI(y) and DWI(z)).
DW-MRS spectra were acquired over 3 b-values of 30, 1640 and 3857 s/mm2, TE/TR=64/2500 ms with 120 averages was used to achieve a total scan time of 15 min.
Table 1 Normalized signal intensities (mean ± SD) for only NTG cohorts
Table 2 ADC measurements (mean ± SD) for only NTG cohorts
Statistical significances are *p<0.05 (LSD) for comparisons with the saline control (data not shown).